3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Ovarian Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durán, GE; Lau, DH; Sikic, BI | 1 |
| Durán, GE; Lau, DH; Lewis, AD; Sikic, BI | 1 |
| Ehsan, MN; Lau, DH; Lewis, AD; Sikic, BI | 1 |
| Lau, DH; Ross, KL; Sikic, BI | 1 |
| Acton, EM; Brown, BW; Ehsan, MN; Friend, NF; Hacker, MP; Harker, WG; Newman, RA; Sikic, BI | 1 |
5 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Ovarian Neoplasms
| Article | Year |
|---|---|
Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.
Topics: Antibiotics, Antineoplastic; Biotransformation; DNA, Neoplasm; Doxorubicin; Female; Humans; Microsomes, Liver; NADP; Ovarian Neoplasms; Plasmids; Tumor Cells, Cultured | 1992 |
Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism.
Topics: Antibiotics, Antineoplastic; Buthionine Sulfoximine; Cell Survival; Doxorubicin; Drug Resistance; Ethacrynic Acid; Female; Glutathione; Humans; In Vitro Techniques; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured | 1992 |
Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Topics: Bleomycin; Blotting, Western; Carmustine; Cisplatin; Cross Reactions; Dinitrochlorobenzene; DNA; DNA Repair; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Female; Gamma Rays; gamma-Glutamyltransferase; Glutathione; Glutathione Reductase; Glutathione Transferase; Humans; In Vitro Techniques; Methionine; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured; Vinblastine | 1991 |
Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin.
Topics: Cross-Linking Reagents; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance; Female; Humans; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured | 1990 |
Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Humans; Isoenzymes; L-Lactate Dehydrogenase; Mice; Myocardium; Ovarian Neoplasms; Pregnancy | 1985 |